Das diabetische Fußsyndrom

Schlüsselwörter

diabetisches Fußsyndrom - Charcot-Fuß - Risikofaktoren - Epidemiologie - Revaskularisation - Wundbehandlung - Infektionen

Keywords

diabetic foot syndrome - Charcot‘s foot - risk factors - epidemiology - revascularization - wound therapy - infections

• Literatur

• 1 Apelquist J, Elgzyri T, Larsson J et al. Factors related to outcome of neuroischemic/ischemic foot ulcers in diabetic patients. J Vasc Surg 2011; 53: 1582-1588
• 2 Bharara M, Schoess J, Armstrong DG. Coming events cast their shadow before: detecting inflammation in the acute diabetic foot and the foot in remission. Diab Metab Rev Res 2012; 28: 15-20
• 3 El-Hilaly R, Elshazly O, Amer A. The role of total contact insole in diminishing foot pressures following partial first ray amputation in diabetic patients. Foot 2013; 23: 6-10
• 4 Feng YU, Schlösser FJ, Bauer ES. The Semmes Weinstein monofilament examination is a significant predictor of the risk of foot ulceration and amputation in patients with diabetes mellitus. J Vasc Surg 2011; 53: 220-226
• 5 Fleischer AE, Wrobel JS, Leonards A et al. Post-treatment leucocytosis predicts an unfavourable clinical response in patients with moderate to severe diabetic foot infection. J Foot Ankle Surg 2011; 50: 541-46
• 6 Game FL, Hinchcliffe RJ, Apelquist J et al. A systematic review of interventions to enhance the healing of chronic foot ulcers of the foot in diabetes. Diabetes Res Rev 2012; 28: 119-141
• 7 Kärvestedt L, Märtensson E, Grill V et al. The prevalence of peripheral neuropathy in a population-based study of patients with type 2 diabetes in Sweden. J Diabetes 2011; 25: 97-106
• 8 Lauterbach S, Kostev K, Kohlmann T. Prevalence of diabetic foot syndrome and its risk factors in the UK. J Wound Care 2010; 19: 333-337
• 9 Leese GP, Feng Z, Leese RM et al. Impact of health-care accessibility and social deprivation on diabetes related foot disease. Diabetic Med 2013; 30: 484-490
• 10 Lepäntalo M, Fiengo L, Biancari F. Peripheral arterial disease in diabetic patients with renal insufficiency. Diabetes Metab Res Rev 2012; 28: 40-45
• 11 Lipsky BA, Peters EJG, Senneville E et al. Expert opinion on the management of infections in the diabetic foot. Diab Metab Res Rev 2012; 28: 163-178
• 12 Monteiro-Soares M, Boyko EJ, Ribeiro J et al. Risk stratification systems for diabetic foot ulcers: a systematic review. Diabetologia 2011; 54: 1190-1199
• 13 Nordrheinische Gemeinsame Einrichtung Disease Management Programme GbR. Qualitätssicherungsbericht 2009 – Disease-Management-Programme in Nordrhein. http://www.kvno.de/downloads/quali/qualbe_dmp09.pdf (letzter Zugriff 16.10.2013)
• 14 Pearce BJ, Toursarkissian B. The current role of endovascular intervention in the management of diabetic peripheral arterial disease. Diab Foot Ankle 2012; 3: doi 10.3402
• 15 Pscherer S, Dippel FW, Lauterbach S et al. Amputation rate and risk factors in type 2 patients with diabetic foot syndrome under real-life conditions in Germany. Prim Care Diabetes 2012; 6: 241-46
• 16 Reekers JA, Lammers J. Diabetic foot and PAD: the endovascular approach. Diabetes Metab Res Rev 2012; 28: 36-39
• 17 Rogers LC, Frykberg RG, Armstrong DG et al. The Charcot foot in diabetes. Diabetes Care 2011; 34: 2123-2129
• 18 Santosa F, Maysidi T, Kanja S et al. Decrease in major amputations in Germany. Int Wound J Jun 6 doi. 2013; [Epub ahead of print]
• 19 Schaper NC, Andros G, Apelquist J et al. Diagnosis and treatment of peripheral arterial disease in diabetic patients with a foot ulcer. A progress report of the International Working Group on the Diabetic Foot. Diabetes Metab Res Rev 2012; 28: 218-224
• 20 Senneville E, Gaworowska D, Topolinski H et al. Outcome of patients with diabetes with negative percutaneous bone biopsy performed for suspicion of osteomyelitis of the foot. Diabetes Care 2012; 29: 56-61
• 21 Vamos EP, Bottle A, Edmonds ME et al. Changes in the incidence of lower extremity amputations in individuals with and without diabetes in England between 2004 and 2008. Diabetes Care 2010; 33: 2592-2597
• 22 Van Battum P, Schaper N, Prompers L et al. Differences in minor amputation rate in diabetic foot disease throughout Europe are in part explained by differences in disease severity at presentation. Diabetes Med 2011; 28: 199-205
• 23 Venermo M, Biancari F, Arvela E et al. The role of kidney disease as a predictor of outcome after revascularisation of ulcerated diabetic foot. Diabetologia 2011; 54: 2971-2977
• 24 Weiner RD, Viselli SJ, Fulkert KA et al. Histology versus microbiology for accuracy in identification of osteomyelitis in the diabetic foot. J Foot Ankle Surg 2011; 50: 197-200
• 25 Zhao Y, Ye W, Boye KS et al. Prevalence of other diabetes-associated complications and comorbidities and its impact on health care charges among patients with diabetic neuropathy. J Diabetes 2010; 9: 9-19
• 26 Zampa V, Bargellini I, Rizzo L et al. Role of Dynamic MRI in the follow-up of acute Charcot foot in patients with diabetes mellitus. Skeletal Radiol 2011; 40: 991-999